Personalized Medicine

In this video from the Annual Meeting of the American Neurological Association, Conrad "Chris" Weihl, MD, PhD, discusses the plenary session he co-chaired on the genomics of personalized medicine.

Our understanding of pancreatic cancer biology is advancing rapidly.

There is much to look forward to in the management of psoriatic arthritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

Physician burnout is common in all aspects of medicine.

An intervention implemented in primary care settings reduced serious fall injuries among older adults but was not as effective as expected, according to a study published in the New England Journal of Medicine.

For Laura Q.M. Chow, MD, medical oncologist at Seattle Cancer Care Alliance and professor of medicine in the division of medical oncology at the University of Washington, there is still much to be done to improve the quality of life and survival of patients with lung cancer until it is eradicated — starting with identification of better biomarkers to personalize therapy and development of novel therapies to improve response and survival in clinical trials.

Healio spoke with Karen L. Reckamp, MD, MS, medical director of clinical research operations, co-director of the thoracic oncology program, and professor in the department of medical oncology at City of Hope Comprehensive Cancer Center in Duarte, California, about her research in immunotherapy treatments for non-small cell lung cancer and the role of genetics to better target individual therapies for patients with lung cancer.

In this Editorial, Jeff Balser, MD, PhD, President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine, discusses the challenges of interpreting commercial genetic test results to patients and reviews tools that are being developed by researchers at Vanderbilt University Medical Center to help clinicians manage patients based on their genomic information.

AUSTIN, Texas — Inflammatory bowel disease can vary drastically from patient to patient. There is not a one-size-fits-all therapy that can handle all that variance. At the Crohn’s and Colitis Congress, experts provided an overview of the numerous IBD therapies to provide the attending physicians with some baseline knowledge before they started with the scientific sessions.